Clinical trial
Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine
NCT06525974 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine
- Lead sponsor
- Tanta University
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- September 1, 2024
- Completion date
- December 30, 2026
- Enrollment
- 46 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis